Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Rhea-AI Summary

Charles River Labs to present at investor conferences, providing strategic focus and business developments

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including:

• Morgan Stanley 21^st Annual Global Healthcare Conference on Tuesday, September 12^th, at 10:10 a.m. EDT; and
• Baird 2023 Global Healthcare Conference on Wednesday, September 13^th, at 9:05 a.m. EDT.

Management will present an overview of Charles River’s strategic focus, business developments, and recent trends.

A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for at least two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230911172667/en/

Investor Relations:

Todd Spencer

Corporate Vice President, Investor Relations

781.222.6455

todd.spencer@crl.com

Source: Charles River Laboratories International, Inc.